These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A Vicious NGF-p75 Tringali G; Pizzoferrato M; Lisi L; Marinelli S; Buccarello L; Falsini B; Cattaneo A; Navarra P Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003427 [TBL] [Abstract][Full Text] [Related]
6. Detailed characterization of the biological activities of recombinant human nerve growth factor expressed in Chinese hamster ovary cells. Kakihana M; Kato K; Fukumoto H; Fujiwara E; Iwane M; Suno M Mol Chem Neuropathol; 1993; 18(1-2):51-83. PubMed ID: 8466595 [TBL] [Abstract][Full Text] [Related]
7. Characterization of ultra-high affinity monoclonal antibodies with a dimeric, symmetrical antigen: inhibition of the receptor recognition site of nerve growth factor. Vroegop SM; Crumm E; Buxser SE Mol Immunol; 1992 Mar; 29(3):411-23. PubMed ID: 1313539 [TBL] [Abstract][Full Text] [Related]
8. Biologically active human and mouse nerve growth factors secreted by the yeast Saccharomyces cerevisiae. Nishizawa M; Ozawa F; Higashizaki T; Hirai K; Hishinuma F Appl Microbiol Biotechnol; 1993 Feb; 38(5):624-30. PubMed ID: 7763473 [TBL] [Abstract][Full Text] [Related]
9. A common mechanism for recombinant human NGF, BDNF, NT-3, and murine NGF slow unfolding. De Young LR; Schmelzer CH; Burton LE Protein Sci; 1999 Nov; 8(11):2513-8. PubMed ID: 10595557 [TBL] [Abstract][Full Text] [Related]
10. A single Mr approximately 103,000 125I-beta-nerve growth factor-affinity-labeled species represents both the low and high affinity forms of the nerve growth factor receptor. Green SH; Greene LA J Biol Chem; 1986 Nov; 261(32):15316-26. PubMed ID: 3021771 [TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibodies against beta nerve growth factor and their effects on receptor binding and biological activity. Zimmermann A; Sutter A; Shooter EM Proc Natl Acad Sci U S A; 1981 Jul; 78(7):4611-5. PubMed ID: 6270686 [TBL] [Abstract][Full Text] [Related]
12. Development of a non invasive NGF-based therapy for Alzheimer's disease. Covaceuszach S; Capsoni S; Ugolini G; Spirito F; Vignone D; Cattaneo A Curr Alzheimer Res; 2009 Apr; 6(2):158-70. PubMed ID: 19355851 [TBL] [Abstract][Full Text] [Related]
14. A comparison of binding properties and structure of NGF receptor on PC12 pheochromocytoma and A875 melanoma cells. Buxser SE; Watson L; Johnson GL J Cell Biochem; 1983; 22(4):219-33. PubMed ID: 6323498 [TBL] [Abstract][Full Text] [Related]
15. Mutation of tryptophan-21 in mouse nerve growth factor (NGF) affects binding to the fast NGF receptor but not induction of neurites on PC12 cells. Drinkwater CC; Suter U; Angst C; Shooter EM Proc Biol Sci; 1991 Dec; 246(1317):307-13. PubMed ID: 1686097 [TBL] [Abstract][Full Text] [Related]
17. Properties of the nerve growth factor receptor. Relationship between receptor structure and affinity. Buxser S; Puma P; Johnson GL J Biol Chem; 1985 Feb; 260(3):1917-26. PubMed ID: 2981877 [TBL] [Abstract][Full Text] [Related]
18. Fast and slow nerve growth factor binding sites in human neuroblastoma and rat pheochromocytoma cell lines: relationship of sites to each other and to neurite formation. Sonnenfeld KH; Ishii DN J Neurosci; 1985 Jul; 5(7):1717-28. PubMed ID: 4020417 [TBL] [Abstract][Full Text] [Related]
19. PC12 cell mutants that possess low- but not high-affinity nerve growth factor receptors neither respond to nor internalize nerve growth factor. Green SH; Rydel RE; Connolly JL; Greene LA J Cell Biol; 1986 Mar; 102(3):830-43. PubMed ID: 3005338 [TBL] [Abstract][Full Text] [Related]
20. Characterization of functional nerve growth factor-receptors in a CNS glial cell line: monoclonal antibody 217c recognizes the nerve growth factor-receptor on C6 glioma cells. Kumar S; Huber J; Peña LA; Perez-Polo JR; Werrbach-Perez K; de Vellis J J Neurosci Res; 1990 Nov; 27(3):408-17. PubMed ID: 1965839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]